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Volume 58, Number 4 Abstracts 1149diagnostic imaging, and access-related procedures including those pertain-
ing to access maturation. These events were designated as occurring within
either the ﬁrst or second year of functional access patency. Current proce-
dural terminology codes were used to calculate the unadjusted Medicare,
or “national average,” reimbursement in 2012 US dollars for these events
as outpatient hospital encounters. Bivariate analysis using linear modeling
and one-way analysis of variance was used to assess differences in mean
cost.
Results: RCFs and BCFs had higher 1-year functional patency costs
in females than in males ($19,257 vs $15,089 and $17,275 vs $13,819)
regardless of age. This remained statistically signiﬁcant with respect to 2-
year functional patency ($48,362 vs $42,372 and $43,361 vs $37,651).
RCF and BCF were costlier in patients over the age of 70 than BBF
($23,492 vs $22,984 vs $14,089) regardless of gender over the ﬁrst year
of access functional patency. This difference remained at 2 years as well
($53,251 vs $56,261 vs $39,372). Among females over age 70, the cost
of maintaining BBF was less expensive than in males or younger females
($13,247 vs $16,668 or $15,827) during the ﬁrst year as well as the second
year ($33,374 vs $44,726 or $44,324). All mentioned differences demon-
strated statistical signiﬁcance with a P value of <.05.
Conclusions: Sex, age, and anatomic location may correlate with cost
differences in maintaining 1- and 2-year functional patency of AVFs. These
ﬁnancial differences may further be stratiﬁed by patient demographics.
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Objectives: Atherosclerosis (AthSc) is escalated by the excessive accu-
mulation of oxidized low density lipoprotein (OxLDL). A new class of
nanopolymers, termed nanolipoblockers (NLB), has previously demon-
strated inhibition of OxLDL uptake by macrophages. Using an ex vivo
human carotid plaque model for targeted intervention with NLB offers
potential new mechanisms of AthSc treatment.
Methods: Carotid plaques were sectioned and incubated in culture
medium at 37C. Samples were treated with the NLBs of different polymer
chemistries and 5 mg/mL oxLDL to evaluate NLB binding to plaque and to
assess inhibition of plaque recruitment of OxLDL and effect on inﬂamma-
tion. Samples were digested, homogenized, ﬁltered, and ﬂuorescence quan-
tiﬁed by ﬂow cytometry and confocal microscopy to identify plaque
composition, NLB, and oxLDL uptake.
Results: Plaque cells were identiﬁed in the specimen showing high
levels of NLB binding, merely within 5 minutes, with an increase in uptake
in a chemistry-dependent manner after 24 hours (Fig 1). NLBs lowered
inﬂammatory markers in the presence of oxLDL. Furthermore, NLBs
caused a marked decrease in the uptake of OxLDL in plaque (Fig 2).
Conclusions: AthSc plaques could be targeted through NLB inter-
vention via a reduction in inﬂammatory substrates and multicellular OxLDLFig 1.uptake inhibition. This ex vivo model and the NLBs provide a promising
therapeutic strategy for the management of active AthSc.
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Objectives: Impending changes to hospital reimbursement has
focused attention on the signiﬁcant impact of unplanned hospital readmis-
sions on both patients and providers alike. Vascular surgery patients have
high readmission rates and identiﬁcation of high-risk groups that may be
amenable to targeted interventions is an important strategy for readmission
prevention. This study aimed to determine predictors of unplanned read-
mission and develop a risk score for predicting readmissions after vascular
surgery.
Methods: The National Surgical Quality Improvement Program
database for 2011 was queried for major vascular surgical procedures. The
primary end point was unplanned 30-day readmissions. The data was
randomly split into two-thirds for development and one-third for validation.
Multivariate logistic regression was used to create and validate a point score
system to predict unplanned readmissions.
Results: Overall 24,310 patients were included, with 2464 readmis-
sions (10.1%). A point based scoring system was developed based on
multivariate logistic regression for factors predictive for readmission
(Table). The scoring system developed included procedure type (open
abdominal aortic aneurysm ¼ 3 points, peripheral intervention 5 points,
amputation ¼ 1 point), graft failure prior to discharge (5 points), veno-
thromboembolism prior to discharge (4 points), discharge destination
(facility that was home ¼ 3-points, new facility or rehab ¼ 2 points), Black
race (1 point), nonelective presentation (1 point), pulmonary (2 points),
cardiac (2 points), renal (1 point) comorbidities, chronic steroid use (2
points), hypoalbuminemia (2 points), anemia (2 points), diabetes (1
point), bleeding disorder (1 point), operative time $150 minutes (1
point), and bleeding disorder (1 point). The point score was used to
stratify patients into three groups: low risk (0-3 points) with a readmission
rate of 5.4%, moderate risk (4-7 points) with a readmission rate of 8.6%,
and high risk ($8 points) with a readmission rate of 16.4%. The model had
good predictive ability (c-statistic ¼ 0.67).
Conclusions: Using patient, operative, and predischarge events, this
novel vascular surgery speciﬁc readmission score accurately identiﬁed
patients at high risk for 30-day unplanned readmission. This model could
help direct discharge and home health care resources to patients at high
risk, ultimately reducing readmissions and improving efﬁciency.
